Sanders Corazon (corsee) D. - Net Worth and Insider Trading

Over the past 18 months, Sanders Corazon (corsee) D. made no insider transaction in BeiGene Ltd (BGNE). Other recent insider transactions involving BeiGene Ltd (BGNE) include a net sale of 120,245 shares made by John Oyler , a net sale of 3,156 shares made by Julia Aijun Wang , and a net sale of 15,269 shares made by Xiaobin Wu .

In summary, during the past 3 months, insiders sold 18,987,005 shares of BeiGene Ltd (BGNE) in total and bought 0 shares, with a net sale of 18,987,005 shares. During the past 18 months, 20,220,106 shares of BeiGene Ltd (BGNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 20,220,106 shares.

BeiGene Ltd (BGNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Sanders Corazon (corsee) D. made no insider transaction in Molecular Templates Inc (MTEM). Other recent insider transactions involving Molecular Templates Inc (MTEM) include a net purchase of 3,225,499 shares made by Biotech Target N V ,

In summary, during the past 3 months, insiders sold 1,279,820 shares of Molecular Templates Inc (MTEM) in total and bought 0 shares, with a net sale of 1,279,820 shares. During the past 18 months, 1,279,820 shares of Molecular Templates Inc (MTEM) were sold and 533,688 shares were bought by its insiders, resulting in a net sale of 746,132 shares.

Molecular Templates Inc (MTEM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Sanders Corazon (corsee) D. made 3 insider transaction in Ultragenyx Pharmaceutical Inc (RARE) with a net sale of 2,906. Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 156,126 shares made by Emil D Kakkis , a net sale of 3,565 shares made by Theodore Alan Huizenga , and a net sale of 52,398 shares made by Thomas Richard Kassberg .

In summary, during the past 3 months, insiders sold 15,738 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 15,738 shares. During the past 18 months, 264,892 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 264,892 shares.

Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.